Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

Next Previous
X
Search
Trial Profile

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DNV 3837 (Primary)
  • Indications Clostridium difficile infections
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Deinove

    • Most Recent Events

    • 06 Oct 2022 According to a Deinove media release, patient case data from the ongoing Phase II trial were presented at the ESCMID/ASM Conference in Dublin on October 5, 2022.
    • 05 Oct 2022 Results published in the Media Release
    • 05 Oct 2022 According to a Deinove media release, a case study excerpted from this study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top